Scholars Central

Conference abstractPublished 2 Nov 2017

Development and characterization of a microparticulate vaccine formulation for metastatic breast cancer

Authors: Rokon Uz Zaman, Rikhav P Gala, Nihal S Mulla, Martin J D’Souza

Mercer University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Breast cancer is the most fatal form of cancer in females. Even with early diagnosis, 20% of women still develop metastases. Immunotherapy is being explored to provide a better treatment option, as current therapies against breast cancer are mostly invasive and pose numerous adverse effects. With this in mind, our purpose has been to formulate and evaluate a micro particulate therapeutic vaccine to provide a new line of therapy for metastatic breast cancer. Murine breast cancer cell line 4T1 was used as source of antigens. Vaccine microparticles were prepared by encapsulating 4T1 tumor associated antigens in cellulose polymer using spray dryer technology. Total protein concentration of the whole cell lysate was determined by Bio-Rad total protein assay. In vitro characterization of microparticles was conducted. In vitro innate immune response was determined by performing nitric oxide assay. Expression of surface co-stimulatory molecules on dendritic cells treated with vaccine microparticles and other controls were determined by flow cytometer using different markers (CD40, CD80, MHCI and MHC II). The yield of the microparticulate vaccine, following spray drying was 80Ã?±5% w/w. Total protein content of whole cell lysate was 3.48Ã?±1.25 mg/mL. The particle size was 1-4 Ã?µm. Zeta potential was -7Ã?±2 mV. There were significantly higher amount of nitric oxide released in the supernatant of cells exposed to vaccine microparticles compared to blank microparticles. CD40, MHC II and CD80, MHC I expression were significantly higher in the vaccine microparticles group compared to blank microparticles and vaccine suspension group.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical and Cellular Immunology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical and Cellular Immunology
  • SubjectImmunology & Microbiology
  • BylineArticles whose byline prints “Rokon Uz Zaman”
  • BylineArticles whose byline prints “Rikhav P Gala”
  • BylineArticles whose byline prints “Nihal S Mulla”
  • BylineArticles whose byline prints “Martin J D’Souza”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels